References
- Bagshawe KD. Clinical applications of HCG. Advances in experimental medicine and biology. Vol. 176: Human trophoblastic neoplasms, R A Pattilo, R O Hussa. Plenum, New York 1982; 313–24
- Miyasaka Y, Hachiya J, Furuya Y, Seki T, Watanabe H. CT evaluation of invasive trophoblastic disease. J Comput Assist Tomogr 1985; 9: 459–62
- Woo J SK, Wong L C, Ma H-K. Sonographic patterns of pelvic and hepatic lesions in persistent trophoblastic disease. J Ultrasound Med 1985; 4: 189–98
- Borell U, Fernstrom I, Westman A. Value of pelvic arterio-graphy in diagnosis of mole and chorionepithelioma. Acta Radiol 1955; 44: 378–83
- Cockshott W P, Evans K T, deV Hendrickse JP. Arteriography of trophoblastic tumors. Clin Radiol 1964; 15: 1–8
- Cockshott WP. deV Hendrickse JP Persistent arteriovenous fistulae following chemotherapy of malignant trophoblastic disease. Radiology 1967; 88: 329–33
- Brewis R AL, Bagshawe KD. Pelvic arteriography in invasive trophoblastic neoplasia. Br J Radiol 1968; 41: 481–95
- Hricak H, Demas B, Braga C, Fisher M, Winkler M. Gestational trophoblastic neoplasm of the uterus: MR assessment. Radiology 1986; 161: 11–6
- Disaia P J, Creasman WT. Gestational trophoblastic neoplasia. Clinical gynecological oncology, ed. 4. Mosby-Year Book, St Louis 1993; 210–37
- Hricak H, Tscholakoff D, Heinrichs LeR. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology 1986; 158: 385–91
- Hricak H. MRI in the female pelvis. AJR 1986; 146: 1115–23